June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Release of fluconazole from daily disposable contact lenses using a novel in vitro eye model
Author Affiliations & Notes
  • Chau-Minh Phan
    Vision Science, University of Waterloo, Waterloo, ON, Canada
  • Lyndon William Jones
    Vision Science, University of Waterloo, Waterloo, ON, Canada
  • Lakshman N Subbaraman
    Vision Science, University of Waterloo, Waterloo, ON, Canada
  • Magdalena Bajgrowicz
    Wroclaw University of Technology, Wroclaw, Poland
  • Footnotes
    Commercial Relationships Chau-Minh Phan, None; Lyndon Jones, None; Lakshman Subbaraman, None; Magdalena Bajgrowicz, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3085. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chau-Minh Phan, Lyndon William Jones, Lakshman N Subbaraman, Magdalena Bajgrowicz; Release of fluconazole from daily disposable contact lenses using a novel in vitro eye model. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3085.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: The burst release of a drug followed by a plateau phase is a common observation with drug delivery studies using soft contact lenses (CLs). However, this phenomenon could be attributed to the properties of the release system. The aim of this study was to evaluate and compare the release of fluconazole from a variety of daily disposable (DD) CLs using a conventional vial-based method with a novel in vitro eye model.

Methods: An eye model was created using two 3-D printed molds, which were filled with polydimethylsiloxane (PDMS) to obtain a model that mimics the eyeball and eyelid. The model was integrated with a microfluidic syringe pump, and the flow-through was collected in a 12‑well microliter plate. Four commercially available DD conventional hydrogel (CH) CLs (nelfilcon A, omafilcon A, etafilcon A, ocufilcon B) and three silicone hydrogel (SH) CLs (somofilcon A, narafilcon A, delefilcon A) were evaluated. These lenses were incubated with fluconazole for 24 h. The release of the drug was measured in (1) a vial containing 4.8 mL of PBS and (2) in the novel PDMS eye model with a 4.8 mL tear flow over 24 h. The uptake and release of the drug was monitored by absorbance at 259 nm.

Results: Overall, CH CLs had a higher uptake and release of fluconazole than SH CLs (p<0.05). A higher drug release was observed in the vial condition compared to the eye model (p<0.001). Total drug release in the vial varied between 47.8±14.6 - 191.9±15.0 µg/lens, compared to the release in the eye model, which ranged between 45.2±3.75 - 137.5±13.8 µg/lens. In the vial system, the drug was rapidly released from the CL within the first 2 hrs, followed by a plateau phase. In contrast, drug release in the eye model was sustained, and did not reach a plateau over 24 hrs (p<0.05). Both models were in agreement as to which lenses released the highest (ocufilcon B) and lowest (nelfilcon A and narafilcon A) amount of drug.

Conclusions: A novel in vitro model that mimics tear flow across the ocular surface has been successfully developed, which can be used for determining drug release from CLs. Results suggest that the previously reported rapid drug release and plateau phenomenon results from using a large volume vial as the release system. Under low volume at physiological tear flow, commercial CLs can maintain a sustained drug release profile for up to 24 hrs, suggesting their potential as ocular drug delivery devices.<br />


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.